loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 203093 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ELVITEGRAVIR (2)

filter

01 GILEAD SCIENCES INC (2)

filter

01 TABLET;ORAL (2)

filter

01 150MG (1)

02 85MG (1)

filter

01 USA (2)

URL Supplier Web Content
TABLET;ORAL
85MG
VITEKTA
USA
203093
2014-09-24
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
150MG
VITEKTA
USA
203093
2014-09-24
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 203093

Looking for CTD TGA MCC DOSSIER APPLICATION 203093 2

19

Gilead Sciences, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ELVITEGRAVIR, with a corresponding application number 203093 and regulatory information .

proudly manufactured in the

approval since 2014-09-24

Gilead Sciences's VITEKTA TABLET;ORAL, medication with 85MG of ELVITEGRAVIR.

18

Gilead Sciences, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ELVITEGRAVIR, with a corresponding application number 203093 and regulatory information .

proudly manufactured in the

approval since 2014-09-24

Gilead Sciences's VITEKTA TABLET;ORAL, medication with 150MG of ELVITEGRAVIR.

Post Enquiry
POST ENQUIRY